According to Orthofix Medical 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.9652. At the end of 2025 the company had a P/S ratio of 0.7790.
Year | P/S ratio | Change |
---|---|---|
2025 | 0.7790 | -7.03% |
2024 | 0.8379 | 26.26% |
2023 | 0.6636 | -25.58% |
2022 | 0.8917 | -32.53% |
2021 | 1.32 | -35.34% |
2020 | 2.04 | 7.02% |
2019 | 1.91 | -11.28% |
2018 | 2.15 | -6.36% |
2017 | 2.30 | 46.06% |
2016 | 1.57 | -14.71% |
2015 | 1.85 | 32.69% |
2014 | 1.39 | 33.95% |
2013 | 1.04 | -39.63% |
2012 | 1.72 | 39.12% |
2011 | 1.24 | 35.72% |
2010 | 0.9109 | -6.26% |
2009 | 0.9717 | 92.61% |
2008 | 0.5045 | -74.96% |
2007 | 2.01 | -10.5% |
2006 | 2.25 | 10.42% |
2005 | 2.04 | -4.85% |
2004 | 2.14 | -40.53% |
2003 | 3.60 | 66.65% |
2002 | 2.16 | -26.12% |
2001 | 2.93 |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
![]() NuVasive NUVA | 1.70 | 209.23% | ๐บ๐ธ USA |
![]() Smith & Nephew
SNN | 2.96 | 437.94% | ๐ฌ๐ง UK |
![]() Stryker Corporation SYK | 6.45 | 1,073.66% | ๐บ๐ธ USA |
![]() Globus Medical GMED | 3.09 | 462.01% | ๐บ๐ธ USA |